Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 | MicrobiomeTrials← Back to trialsNCT04397588
Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19
CompletedOBSERVATIONAL
Trial Details
Start: 2020-04-21Est. Completion: 2022-05-24
Enrollment target: 761 participants Locations- Angers University Hospital, Angers, France
- Besançon Hospital, Besançon, France
- Brest university Hospital, Brest, France
- Caen University Hospital, Caen, France
- Clermont ferrand University hospital, Clermont-Ferrand, France
- APHP Henri Mondor Paris University Hospital, Créteil, France
- Dijon University Hospital, Dijon, France
- Vendée Hospital, La Roche-sur-Yon, France
- Grenoble University Hospital, La Tronche, France
- APHP Kremli Bicetre Paris University Hospital, Le Kremlin-Bicêtre, France
- Marie Lannelongue Hospital, Le Plessis-Robinson, France
- Lens Hospital, Lens, France
- Lille University Hospital, Lille, France
- Limoges University Hospital, Limoges, France
- Clinique de la Sauvegarde, Lyon, France
- Lyon University Hospital, Lyon, France
- Marseille Européen Hospital, Marseille, France
- APHM la Timone- Marseille University Hospital, Marseille, France
- Clairval Hospital, Marseille, France
- Metz University Hospital, Metz, France
- Montpellier University Hospital, Montpellier, France
- Emile Muller Hospital, Mulhouse, France
- Nancy University Hospital, Nancy, France
- Nantes University Hospital, Nantes, France
- Ambroise Paré Hospital, Neuilly-sur-Seine, France
- Nimes University Hospital, Nîmes, France
- Institut Mutualiste Montsouris, Paris, France
- APHP Hopital Européen Georges Pompidou - Paris University Hospital, Paris, France
- APHP necker Paris University Hospital, Paris, France
- APHP Bichat - Paris University Hospital, Paris, France
- APHP La Pitié Salpêtrière Paris University Hospital, Paris, France
Other microbiome trials you might be interested in
COVID-19SARS-CoV-2 InfectionSevere Acute Respiratory Syndrome Coronavirus 2
A prospective, randomized, placebo-controlled, double-blinded, phase III clinical trial of the therapeutic use of conval…
Bloemfontein, South AfricaCompleted Dec 30, 2021
Covid19SARS-CoV InfectionARDSARDS, Human
Acute treatment of COVID-ARDS with direct topical lung instilled T3 therapy for patients on mechanical ventilation.
Bordeaux University Hospital, Pessac, FrancePoitiers University hospital, Poitiers, FranceReims University hospital, Reims, FranceRennes University hospital, Rennes, FranceRouen University Hospital, Rouen, FranceSaint brieuc Hospital, Saint-Brieuc, FranceLa Réunion University Hospital, Saint-Denis, FranceSaint Etienne University Hospital, Saint-Etienne, FranceSaint Nazaire Hospital, Saint-Nazaire, FranceStrasbourg University Hospital, Strasbourg, FranceToulouse University Hospital - Rangueil Hospital, Toulouse, FranceTours University Hospital, Tours, FranceBretagne Atlantique Hospital, Vannes, FranceMinneapolis, United States
Completed Oct 15, 2030